who discovered glp-1 agonists Biochemist named winner of 2026 Kimberly Prize: For Journalists The expanding landscape of GLP-1
Description
To date, the U.S
Corresponding Author: Roger S
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
In May 2024, Lilly disclosed it would more than double its investment in a new Lebanon, Indiana manufacturing campus (already under construction) by allocating an additional $5.3 billion on top of $3.7 billion ( [6] )
doi: 10.1016/j.jada.2010.10.008
Bioinformation 17 (3), 413423
